557 related articles for article (PubMed ID: 19288321)
1. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxic effects in high-risk patients undergoing angiography.
Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy.
Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Lundkvist J
Am Heart J; 2005 Feb; 149(2):298-303. PubMed ID: 15846268
[TBL] [Abstract][Full Text] [Related]
4. A comparison of a non-ionic dimer, iodixanol with a non-ionic monomer, iohexol in low dose intravenous urography.
Skehan SJ; Rasmussen F; Gibney RG; Lindequist S; Moller-Nielsen S; Svaland MG; Kampenes VB; Bjartveit K; Greaney T; Carlsen SD; Masterson J
Br J Radiol; 1998 Sep; 71(849):910-7. PubMed ID: 10195003
[TBL] [Abstract][Full Text] [Related]
5. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty.
Song T; Song M; Ge Z; Li Y; Shi P; Sun M
J Interv Cardiol; 2017 Jun; 30(3):281-285. PubMed ID: 28421628
[TBL] [Abstract][Full Text] [Related]
7. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
[TBL] [Abstract][Full Text] [Related]
8. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.
Cernigliaro JG; Haley WE; Adolphson DP; Jepperson MA; Crook JE; Thomas CS; Parker AS
Clin Imaging; 2016; 40(5):902-6. PubMed ID: 27183138
[TBL] [Abstract][Full Text] [Related]
9. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
10. Image quality and safety after iodixanol in intravenous urography; a comparison with iohexol.
Sundgren PC; Bååth L; Törnquist C; Hougens Grynne B; Kjaersgaard P; Almén T
Br J Radiol; 1996 Aug; 69(824):699-703. PubMed ID: 8949670
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
[TBL] [Abstract][Full Text] [Related]
14. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
[TBL] [Abstract][Full Text] [Related]
15. Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury.
Netti GS; Prattichizzo C; Montemurno E; Simone S; Cafiero C; Rascio F; Stallone G; Ranieri E; Grandaliano G; Gesualdo L
Free Radic Biol Med; 2014 Mar; 68():35-42. PubMed ID: 24300339
[TBL] [Abstract][Full Text] [Related]
16. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
17. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
[TBL] [Abstract][Full Text] [Related]
18. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study.
From AM; Bartholmai BJ; Williams AW; McDonald FS
Acta Radiol; 2008 May; 49(4):409-14. PubMed ID: 18415784
[TBL] [Abstract][Full Text] [Related]
19. Post-marketing surveillance of the safety profile of iodixanol in the outpatient CT setting: a prospective, multicenter, observational study of patient risk factors, adverse reactions and preventive measures in 9953 patients.
Müller FH
Rofo; 2014 Nov; 186(11):1028-34. PubMed ID: 24729407
[TBL] [Abstract][Full Text] [Related]
20. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]